4.7 Article

An Autoimmune Phenotype in Vulvar Lichen Sclerosus and Lichen Planus: A Th1 Response and High Levels of MicroRNA-155

Journal

JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 132, Issue 3, Pages 658-666

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/jid.2011.369

Keywords

-

Categories

Funding

  1. ZonMW
  2. Netherlands Organization for Health Research and Development (AGIKO)
  3. Netherlands Genomics Initiative of NWO
  4. Netherlands Organization for Scientific Research

Ask authors/readers for more resources

Vulvar lichen sclerosus and lichen planus are T-cell-mediated chronic skin disorders. Although autoimmunity has been suggested, the exact pathogenesis of these disorders is still unknown. Therefore, the aim of the current study was to investigate the molecular and immunological mechanisms critical to the pathogenesis of vulvar lichen sclerosus and lichen planus. By using gene expression profiling and real-time RT-PCR experiments, we demonstrated a significantly increased expression of the pro-inflammatory cytokines (IFN gamma, CXCR3, CXCL9, CXCL10, CXCL11, CCR5, CCL4, and CCL5) specific for a Th1 IFN gamma-induced immune response. In addition, BIC/microRNA-155 (miR-155)-a microRNA involved in regulation of the immune response-was significantly upregulated in lichen sclerosus and lichen planus (9.5- and 17.7-fold change, respectively). Immunohistochemistry showed a significant T-cell response, with pronounced dermal infiltrates of CD4(+), CD8(+), and FOXP3(+) cells. In conclusion, these data demonstrate an autoimmune phenotype in vulvar lichen sclerosus and lichen planus, characterized by increased levels of Th1-specific cytokines, a dense T-cell infiltrate, and enhanced BIC/miR-155 expression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

An integrated framework for local genetic correlation analysis

Josefin Werme, Sophie van der Sluis, Danielle Posthuma, Christiaan A. de Leeuw

Summary: Genetic correlation analysis is used to identify phenotypes with shared genetic basis. Traditional approaches may fail in cases where the correlation is confined to specific genomic regions or shows opposing directions at different loci. The LAVA framework introduced here allows for local analysis of genetic correlation, as well as evaluation of local heritabilities and conditional genetic relations between multiple phenotypes.

NATURE GENETICS (2022)

Article Pharmacology & Pharmacy

Development of an optimized and generic cost-utility model for analyzing genome-guided treatment data

Maria-Theodora Pandi, Maria Koromina, Gerasimos Vonitsanos, Peter J. van der Spek, George P. Patrinos, Christina Mitropoulou

Summary: The study developed a generic cost-utility analysis model that provides results consistent with traditional cost-utility analysis, offering useful economic evidence for personalized medicine interventions.

PHARMACOLOGICAL RESEARCH (2022)

Correction Psychiatry

Genome-wide gene-environment interactions in neuroticism: an exploratory study across 25 environments (vol 11, 180, 2022)

Josefin Werme, Sophie van der Sluis, Danielle Posthuma, Christiaan A. de Leeuw

TRANSLATIONAL PSYCHIATRY (2022)

Article Biology

CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue

Job van Riet, Chinmoy Saha, Nikolaos Strepis, Rutger W. W. Brouwer, Elena S. Martens-Uzunova, Wesley S. van de Geer, Sigrid M. A. Swagemakers, Andrew Stubbs, Yassir Halimi, Sanne Voogd, Arif Mohammad Tanmoy, Malgorzata A. Komor, Youri Hoogstrate, Bart Janssen, Remond J. A. Fijneman, Yashar S. Niknafs, Arul M. Chinnaiyan, Wilfred F. J. van IJcken, Peter J. van der Spek, Guido Jenster, Rogier Louwen

Summary: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs) have been discovered in the human genome, termed hCRISPRs, which are expressed as small non-coding RNAs (sncRNAs) and can distinguish normal from malignant tissues. These findings suggest the potential use of hCRISPRs as diagnostic biomarkers for cancer and the development of point-of-care tests based on their differential expression.

COMMUNICATIONS BIOLOGY (2022)

Article Rheumatology

Gain-of-function mutations in ALPK1 cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome

Christina Torres Kozycki, Shilpa Kodati, Laryssa Huryn, Hongying Wang, Blake M. Warner, Priyam Jani, Dima Hammoud, Mones S. Abu-Asab, Yingyos Jittayasothorn, Mary J. Mattapallil, Wanxia Li Tsai, Ehsan Ullah, Ping Zhou, Xiaoying Tian, Ariane Soldatos, Niki Moutsopoulos, Marie Kao-Hsieh, Theo Heller, Edward W. Cowen, Chyi-Chia Richard Lee, Camilo Toro, Shelley Kalsi, Zohreh Khavandgar, Alan Baer, Margaret Beach, Debra Long Priel, Michele Nehrebecky, Sofia Rosenzweig, Tina Romeo, Natalie Deuitch, Laurie Brenchley, Eileen Pelayo, Wadih Zein, Nida Sen, Alexander H. Yang, Gary Farley, David A. Sweetser, Lauren Briere, Janine Yang, Fabiano de Oliveira Poswar, Ida Schwartz, Tamires Silva Alves, Perrine Dusser, Isabelle Kone-Paut, Isabelle Touitou, Salah Mohamed Titah, Petrus Martin van Hagen, Rogier T. A. van Wijck, Peter J. van der Spek, Hiromi Yano, Andreas Benneche, Ellen M. Apalset, Ragnhild Wivestad Jansson, Rachel R. Caspi, Douglas Byron Kuhns, Massimo Gadina, Hidetoshi Takada, Hiroaki Ida, Ryuta Nishikomori, Elena Verrecchia, Eugenio Sangiorgi, Raffaele Manna, Brian P. Brooks, Lucia Sobrin, Robert Hufnagel, David Beck, Feng Shao, Amanda K. Ombrello, Ivona Aksentijevich, Daniel L. Kastner

Summary: This study discovered that ROSAH syndrome is an autoinflammatory disease caused by ALPK1 gene mutations. Patients with ROSAH syndrome often exhibit signs of inflammation and show sensitivity to anti-cytokine therapy.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Genetics & Heredity

Missense variants in ANKRD11 cause KBG syndrome by impairment of stability or transcriptional activity of the encoded protein

Elke de Boer, Charlotte W. Ockeloen, Rosalie A. Kampen, Juliet E. Hampstead, Alexander J. M. Dingemans, Dmitrijs Rots, Lukas Lutje, Tazeen Ashraf, Rachel Baker, Mouna Barat-Houari, Brad Angle, Nicolas Chatron, Anne-Sophie Denomme-Pichon, Orrin Devinsky, Christele Dubourg, Frances Elmslie, Houda Zghal Elloumi, Laurence Faivre, Sarah Fitzgerald-Butt, David Genevieve, Jacqueline A. C. Goos, Benjamin M. Helm, Usha Kini, Amaia Lasa-Aranzasti, Gaetan Lesca, Sally A. Lynch, Irene M. J. Mathijssen, Ruth McGowan, Kristin G. Monaghan, Sylvie Odent, Rolph Pfundt, Audrey Putoux, Jeroen van Reeuwijk, Gijs W. E. Santen, Erina Sasaki, Arthur Sorlin, Peter J. van der Spek, Alexander P. A. Stegmann, Sigrid M. A. Swagemakers, Irene Valenzuela, Eleonore Viora-Dupont, Antonio Vitobello, Stephanie M. Ware, Mathys Weber, Christian Gilissen, Karen J. Low, Simon E. Fisher, Lisenka E. L. M. Vissers, Maggie M. K. Wong, Tjitske Kleefstra

Summary: This study indicates that pathogenic ANKRD11 missense variants cause KBG syndrome with distinct features. Disrupted transrepression capacity and reduced protein stability both result in the loss of ANKRD11 function.

GENETICS IN MEDICINE (2022)

Article Allergy

A germline STAT6 gain-of-function variant is associated with early-onset allergies

Narissara Suratannon, Chupong Ittiwut, Willem A. Dik, Rungnapa Ittiwut, Kornvalee Meesilpavikkai, Nipan Israsena, Praewphan Ingrungruanglert, Virgil A. S. H. Dalm, Paul L. A. van Daele, Anapat Sanpavat, Nataruks Chaijitraruch, Benjamin Schrijver, Supranee Buranapraditkun, Thantrira Porntaveetus, Sigrid M. A. Swagemakers, Hanna IJspeert, Tanapat Palaga, Kanya Suphapeetiporn, Peter J. van der Spek, Nattiya Hirankarn, Pantipa Chatchatee, P. Martin van Hagen, Vorasuk Shotelersuk

Summary: A gain-of-function variant in the STAT6 gene is associated with early-onset multiorgan allergies in humans. This variant leads to spontaneous activation of the STAT6 signaling pathway, resulting in severe allergic phenotypes. The findings contribute to a better understanding of the molecular mechanisms underlying allergies and may open up new therapeutic possibilities.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Letter Immunology

A CDC42 Stop-loss Mutation in a Patient with Relapsing Polychondritis and Autoinflammation

Rogier T. A. van Wijck, Sigrid M. A. Swagemakers, Peter J. van der Spek, P. Martin van Hagen, Paul L. A. van Daele

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Article Genetics & Heredity

CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment

Daphne J. Smits, Jordy Dekker, Rachel Schot, Brahim Tabarki, Amal Alhashem, Jeroen A. A. Demmers, Dick H. W. Dekkers, Antonio Romito, Peter J. van der Spek, Tjakko J. van Ham, Aida M. Bertoli-Avella, Grazia M. S. Mancini

Summary: CLEC16A is a membrane-associated C-type lectin protein that regulates autophagy and mitophagy. It is associated with various auto-immune and neurological disorders and has a role in neurodevelopment. In this study, CLEC16A truncating variants were identified in patients with severe neurodevelopmental disorder. The truncated CLEC16A lost its localization and interaction with other proteins, leading to disrupted vesicle sorting and dysregulated mitophagy. This study highlights the importance of CLEC16A in endosomal sorting and its role in neurodegeneration and brain development.

HUMAN GENETICS (2023)

Article Biochemistry & Molecular Biology

Power and optimal study design in iPSC-based brain disease modelling

Jessie W. Brunner, Hanna C. A. Lammertse, Annemiek A. van Berkel, Frank Koopmans, Ka Wan Li, August B. Smit, Ruud F. Toonen, Matthijs Verhage, Sophie van der Sluis

Summary: This study compares different designs and statistical analysis methods used in iPSC research, and finds that commonly used case-control designs are generally underpowered. The study suggests that multiple isogenic pair designs can increase power and require fewer lines. A free web tool is provided for exploring the power of different study designs using any (pilot) data.

MOLECULAR PSYCHIATRY (2023)

Article Endocrinology & Metabolism

Sex-based differences in cardiovascular proteomic profiles and their associations with adverse outcomes in patients with chronic heart failure

Marie de Bakker, Teun B. Petersen, K. Martijn Akkerhuis, Magdalena Harakalova, Victor A. Umans, Tjeerd Germans, Kadir Caliskan, Peter D. Katsikis, Peter J. van der Spek, Navin Suthahar, Rudolf A. de Boer, Dimitris Rizopoulos, Folkert W. Asselbergs, Eric Boersma, Isabella Kardys

Summary: This study found minimal sex differences in circulating proteins in heart failure patients. The association between sex-specific cardiovascular protein profiles and adverse outcomes may improve understanding of the pathophysiology of heart failure and aid in prognostication in women and men using protein measurements.

BIOLOGY OF SEX DIFFERENCES (2023)

Article Biochemistry & Molecular Biology

Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial

Eelke M. M. Bos, Elena Binda, Iris S. C. Verploegh, Eva Wembacher, Daphna Hoefnagel, Rutger K. K. Balvers, Anne L. L. Korporaal, Andrea Conidi, Esther A. H. Warnert, Nadia Trivieri, Alberto Visioli, Paola Zaccarini, Laura Caiola, Rogier van Wijck, Peter van der Spek, Danny Huylebroeck, Sieger Leenstra, Martine L. M. Lamfers, Zvi Ram, Manfred Westphal, David Noske, Federico Legnani, Francesco DiMeco, Angelo Luigi Vescovi, Clemens M. F. Dirven

Summary: This study evaluates the safety and efficacy of intra- and peritumoral administration of hrBMP4 in recurrent glioblastoma. The results show that local delivery of hrBMP4 is safe and well-tolerated, and some patients responded positively to the treatment. Further clinical studies are warranted.

MOLECULAR CANCER (2023)

Article Multidisciplinary Sciences

Identification of candidate genes for developmental colour agnosia in a single unique family

Tanja C. W. Nijboer, Ellen V. S. Hessel, Gijs W. van Haaften, Martine J. van Zandvoort, Peter J. van der Spek, Christine Troelstra, Carolien G. F. de Kovel, Bobby P. C. Koeleman, Bert van der Zwaag, Eva H. Brilstra, J. Peter H. Burbach

Summary: This study aimed to explore the genomic regions and candidate genes that potentially cause developmental color agnosia. Through genetic analysis and whole exome sequencing, 19 cosegregating chromosomal regions and 11 rare coding variants were identified.

PLOS ONE (2023)

Article Neurosciences

Whole exome sequencing of patients with varicella-zoster virus and herpes simplex virus induced acute retinal necrosis reveals rare disease-associated genetic variants

Johanna L. Heinz, Sigrid M. A. Swagemakers, Joanna von Hofsten, Marie Helleberg, Michelle M. Thomsen, Kerstin De Keukeleere, Joke H. de Boer, Tomas Ilginis, Georges M. G. M. Verjans, Peter M. van Hagen, Peter J. van der Spek, Trine H. Mogensen

Summary: By analyzing the genetic sequencing of ARN patients caused by HSV or VZV, we identified disease-associated genetic variants that are mainly concentrated in genes related to innate immunity, adaptive immunity, autophagy, and apoptosis.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2023)

Article Medicine, General & Internal

HFrEF subphenotypes based on 4210 repeatedly measured circulating proteins are driven by different biological mechanisms

Teun B. Petersen, Marie de Bakker, Folkert W. Asselbergs, Magdalena Harakalova, K. Martijn Akkerhuis, Jasper J. Brugts, Jan van Ramshorst, R. Thomas Lumbers, Rachel M. Ostroff, Peter D. Katsikis, Peter J. van der Spek, Victor A. Umans, Eric Boersma, Dimitris Rizopoulos, Isabella Kardys

Summary: This study identified four distinct subphenotypes of HFrEF based on circulating protein profiles, which had different prognosis and clinical characteristics. These findings can provide insights into the underlying biological mechanisms and personalized treatment opportunities for patients with HFrEF.

EBIOMEDICINE (2023)

No Data Available